Background: Out-of-hospital deaths due to a first myocardial infarction (MI) are frequent and a big challenge for prevention. Increased knowledge about factors influencing MI fatality is needed. Metabolic risk factors have been studied in relation to MI fatality in-hospital but studies considering also out-of-hospital deaths are few. Aim: To assess how diabetes and other metabolic risk factors associate with death within 7 days after first time MI among subjects aged between 45 and 70 identified in Stockholm County 1992-1994. Methods: Data were collected using questionnaires (close relatives of fatal cases were asked to fill the questionnaire), physical examinations, national registers and autopsy reports. Risk ratios (RR) of 7-day MI fatality with 95% confidence intervals (CI) associated with the risk factors under study were calculated using binomial regression with log link. Results: Out of 1905 first time MI cases included, 524 died within 7 days. After adjustments for age, sex, current smoking, education and general comorbidity, diabetes, but not hypertension and hyperlipidemia, was associated with MI fatality (RR 1.68, 95% CI 1.20-2.28). Overweight, as compared to normal BMI, was inversely associated with MI fatality (multiple adjusted RR 0.68, 95% CI 0.49-0.94); obesity results pointed in the same direction (multiple adjusted RR 0.79, 0.52-1.16). Conclusions: In this population-based inception cohort study, diabetes but not hypertension and hyperlipidemia were associated with MI fatality. This further emphasizes the importance of diabetes as a cardiovascular risk factor and the need for close surveillance of diabetic patients. Overweight was however associated with decreased MI fatality.
Introduction
Although coronary heart disease (CHD) mortality shows a declining trend in different populations [1] [2] [3] [4] , the proportion of individuals who die within 28 days from the onset of a first myocardial infarction (MI) is still approximately 30% [1, 2] . The majority of these individuals die out-of-hospital [1] . The knowledge about determinants of MI fatality is limited. Among the traditional cardiovascular risk factors studied in relation to MI fatality, diabetes has gained most attention.
Diabetes was consistently identified as an important risk factor of inhospital MI fatality [5] [6] [7] [8] [9] [10] [11] [12] . Studies that considered also out-of-hospital CHD deaths (referred to here as population based studies) either support diabetes as a risk factor of MI fatality [9, 10] or could not assess it due to limited sample size [13, 14] . None of the population based studies used a narrow definition of MI death out-of-hospital; they used any CHD or sudden death [9, 10, 13, 14] . Further, none of these studies considered overweight and obesity as potential confounding factors. Considering the substantial proportion of CHD deaths occurring out-of-hospital [15] , further studies are needed to clarify the role that diabetes has in MI fatality. It is also important to elucidate whether other metabolic factors such as hypertension, hyperlipidemia, overweight, and obesity influence MI fatality. Among previous investigations of these factors, only a limited number considered out-of-hospital CHD death, and they regarded only hypertension [13] [14] 16] and hyperlipidemia [13] . Results point in different directions.
Typically, previous studies of determinants of MI fatality that did consider out-of-hospital CHD death are cohort studies where the assessment of each respective metabolic risk factor took place many years before the MI event. Thus, exposure information may not accurately mirror the exposure situation at the time of the MI event. Further, previous studies rarely report the proportion of autopsies forming basis for the classification of MI death. Differentiation between fatal MI and sudden death due to other reasons than MI usually requires autopsy [17] .
In the present study, we aimed to assess how diabetes, hypertension, hyperlipidemia, overweight, and obesity, measured close in time to a first MI event, are associated with MI fatality. Although each of these metabolic risk factors has previously been studied in relation to MI fatality, results were most often based solely on admitted MI patients, which may have affected generalizability of results. The present study considers both in-and out-of-hospital deaths. The data forming basis for our study were collected between 1992 and 1994 when the rate of autopsies in Sweden was high: 72% of the fatal MI cases included were ascertained through autopsy.
Materials and methods

Study population
This study is based on material from the Stockholm Heart Epidemiology Program (SHEEP), a study of risk factors for MI performed in Stockholm County among men and women 45-70 years old, residing in Stockholm and who were Swedish citizens. Details about the SHEEP design, including criteria for diagnosis of MI, have earlier been described [18] . Eligible for inclusion in the present inception cohort study were all individuals suffering an MI between 1992 and 1994 in the defined study population without previous hospitalization for MI (International Classification of Diseases, ICD, versions 8 and 9, codes 410 or 412 according to data from the National Patient Register). An additional effort to exclude individuals with previous MI involved asking (using questionnaires) participants whether they had previously been hospitalized due to MI. Those who answered "yes" were phoned and excluded if the prior MI diagnosis was confirmed. MI cases with previous MI, as identified from autopsy reports, but without previous hospitalization for MI recorded were not excluded. Thus, our study is restricted to first known MI cases.
In the SHEEP, 2246 MI cases were identified with a first time documented MI using three sources: 1) coronary units and internal medicine wards for acute care in all Stockholm hospitals; 2) the National Patient Register (ICD 9 code 410 as main or secondary diagnosis); and 3) death certificates (ICD 9 code 410 as main or contributory cause of death) [18] . In the original SHEEP study design, fatal MI was defined as death within 28 days. In 28-day fatal MI cases, MI as a cause of death was ascertained by autopsy data in 69%. The remaining cases were carefully evaluated by the SHEEP secretariat using any available information on disease history and death circumstances. Among the identified cases, 1643 MI cases survived at least 28 days and were considered as non-fatal cases, whereas 603 were considered fatal.
For the main analyses of the current study, we considered as fatal cases only those cases who died out-of-hospital (n = 203), died at the emergency department (n = 170), or died at hospital within 7 days after MI onset (n = 151). Deaths in the latter group occurred either at intensive care units (n = 59), internal medicine wards (n = 35) or any other ward (n = 57). These fatal cases (n = 524) we hereafter refer to as 7-day fatal cases. For supplementary analyses, we considered 28-day fatal cases, comprising the 7-day fatal cases and 79 hospitalized MI cases who died between day 7 and day 28 after the event. Among the 7-day fatal cases who were hospitalized and for whom clinical log data were available (n = 42), the median hospitalization time was 3 days (interquartile range 2-5 days); for non-fatal cases it was 6 days (interquartile range 5-8 days, n = 1272).
The proportion of autopsies among 7-day fatal cases, according to the death certificates, was 72%. From county council archives (mainly Stockholm County) and from forensic medicine departments (in Stockholm, except from one autopsy that took place in Uppsala), we retrieved 49% (n = 186) of the autopsy reports pertaining to 7-day fatal cases. Among the 186 autopsy reports retrieved, 37% were performed by forensic pathologists. The main reason for not retrieving reports from autopsies was that reports sometimes had been discarded due to local restrictions regarding long-term archiving. The missing reports should be a random sample of all autopsies.
All participating non-fatal cases were requested to complete a questionnaire which included questions about life style, body habitus, environmental exposures, psychosocial environment, personal history of disease and family history of disease. Participants were also invited to attend a physical examination which took place on average 6 months after the MI event.
Information about exposures and medical conditions
Most of the data forming bases for this study were retrieved from questionnaires. The vast majority of non-fatal MI cases filled the questionnaires themselves. When the index case could not be contacted or was too ill to fill the questionnaire, a relative was identified and asked to fill the questionnaire in place of the case. The questionnaire was filled by relatives in most of the fatal cases (99.7%) and in a few non-fatal cases (1.5%). The relatives were chosen according to the following priority order: 1) spouse or common-law spouse (49.5%), 2) children older than 18 years old (33.6%), 3) siblings if they were younger than 80 years old (11.0%), 4) parents if they were younger than 80 years old (0.5%), and 5) more distant relatives/friends (5.4%).
The proportion of non-fatal cases participating in SHEEP through completing the questionnaire was 84% whereas in proxies to fatal cases it was 62%. The numbers of MI cases forming basis for the main analyses were 524 7-day fatal cases and 1381 non-fatal cases. The number of participants forming basis for supplementary analyses were 603 28-day fatal cases and 1381 non-fatal MI cases.
Three additional sources were used for retrieving exposure information in the present study: 1) physical examinations (available in 92% of participating non-fatal cases), 2) national registers providing data on diagnoses at previous hospitalizations, number of previous hospitalizations and individual disposable income, 3) autopsy reports (available in 36% of 7-day fatal cases). The information retrieved from autopsy reports was, with the exception of BMI, in general based on either clinical records or statements from close relatives.
Variable definitions
Diabetes was considered present based on either 1) questionnaire data (report of the presence of diabetes, or report of use of antidiabetic medication), 2) register data (main or secondary hospital diagnosis of diabetes [ICD-8 or ICD-9 code 250] at any time before MI diagnosis), or 3) autopsy report data. Hypertension and hyperlipidemia were correspondingly identified. The ICD-8 and ICD-9 codes used for identifying diagnoses of hypertension were 401-404; for identifying hyperlipidemia code 272 was used.
Body mass index (BMI) was calculated from questionnaire data on weight in kilograms and height in centimeters. However, if such information was available from autopsy (27% of 7-day fatal cases with retrieved autopsy reports) or physical examination (83% of non-fatal cases) that information was used. Overweight was defined as a BMI value between 25 kg/m 2 and 30 kg/m 2 , whereas obesity was defined as a BMI of 30 kg/m 2 or above. Individuals with BMI greater than or equal to 18 kg/m 2 , but less than 25 kg/m 2 were considered having "normal BMI", and formed the reference category. Individuals with BMI less than 18 kg/m2 (n = 25) were considered underweight and were excluded from the analyses of overweight and obesity. Previous angina, heart failure, stroke, and intermittent claudication were identified using questionnaire data, data retrieved from autopsy reports or register-based information (main or secondary diagnosis) using the following ICD 8 and ICD 9 codes: 411 and 414 (angina), 428 (heart failure), 430-438 (stroke) and 440C (intermittent claudication).
Previous cardiovascular disease (CVD) was defined as presence of either angina, heart failure, stroke or intermittent claudication.
Individual disposable income the year preceding the year of the MI event was obtained from Statistics Sweden. A disposable income below the median level among participating non-fatal cases, was considered exposed to low disposable income.
Most of the questionnaire-based variables used in the present study (physical inactivity, current smoking, family history of CVD, job strain, working shifts and educational level) have previously been defined [19] . Parental history of premature cardiac death was defined as MI or sudden cardiac death in any parent before age 65, as reported in questionnaire or identified from the Cause of Death Register (ICD8 and ICD9 codes 410-429; ICD9 codes 785.5 and 785.9; ICD8 code 782).
Using data from the National Patient Register (complete in Stockholm County since 1975 and nationwide since 1987), we counted the number of hospitalizations during the ten years preceding the MI event as indicator of general comorbidity. Hospitalizations due to normal child delivery were not considered. We defined general comorbidity using the median number of hospitalizations in participating nonfatal cases as cut-off; individuals with at least one hospitalization were considered to have "general comorbidity".
Statistical analysis
The risk of death within 7 days among cases (7-day MI fatality) was calculated in different strata of metabolic risk factor status: diabetes, hypertension, hyperlipidemia, and BMI categories. Risk ratio point estimates with 95% confidence intervals (CI) of 7-day MI fatality associated with the different risk factors were calculated using binomial regression with log link. Adjustments were made for age and sex in all analyses. In subsequent analyses, additional potential confounding factors were considered for adjustments: metabolic risk factors (other than the one under study), current smoking, physical inactivity, educational level, low disposable income, family history of CVD, parental history of premature cardiac death, general comorbidity and previous CVD. All confounding variables were dichotomized, except BMI and educational level that were divided in four and three categories respectively. Considering a previous observation of overestimation of level of physical inactivity by proxies to non-fatal MI cases [19] , we did not include this variable in the final adjusted model. The remaining questionnairebased variables considered in the present study were not previously observed to be over-or underestimated by proxies [19] . In the final adjusted model, we did not include previous CVD due to its potential role in the mechanisms by which the metabolic risk factors under study may affect MI fatality. MI cases who survived 7 days but died before 28 days were excluded from the main analyses, but included in supplementary analyses of 28-day MI fatality.
All statistical analyses were performed with R version 3.1.2.
Ethics statement
The SHEEP study was approved by the Ethical Committee at Karolinska Institutet (91:259). Additional approval of the extraction of data from national registers and autopsy reports was granted by the Regional Ethics Committee (2013/1731-31/1). All study participants gave their informed oral consent to be enrolled in the study; at the time the study was initiated (in 1992) forms for written consent were generally not used. An invitation letter was sent by mail to eligible subjects informing about the study. The information included description of the rationale for the study, study aims and study design. The letter also stated that participation was voluntary and that confidentiality was guaranteed. Close relatives of fatal cases were contacted after a minimum of 6 months had passed after the index death; however avoiding contact close in time to the 6 months and 1 year anniversary of the index death. The receiver of the invitation was asked to return the completed questionnaire by mail. Employees at the SHEEP central received the questionnaires and contacted each respondent by telephone, asking about clarification of unclear answers and documenting informed consent to participate. A second letter of invitation, a reminder, was sent to those who did not reply to the first letter, and the same procedure for documentation of oral consent was used. Table 1 presents distributions of exposures and conditions in 7-day fatal cases and non-fatal cases. As compared to non-fatal cases, fatal cases were on average 2 years older and the proportion of women was higher. Further, physical inactivity, diabetes, heart failure, previous stroke, general comorbidity, a parental history of premature cardiac death, low disposable income, job strain and working shifts were more common. Obesity, current smoking and previous diagnosis of hyperlipidemia, hypertension, intermittent claudication, angina and educational level were similarly distributed between fatal and non-fatal cases whereas overweight and a family history of CVD were less common among fatal cases than non-fatal cases. Treated diabetes was less common among fatal MI (75%) cases than among non-fatal (81%). Among cases with hyperlipidemia statins were used by 3% of non-fatal cases and by 0% of fatal cases.
Results
As shown in table 2, diabetes was in crude analysis associated with a 52% increased risk of dying within 7 days after the MI. The risk ratios of 7-day MI fatality associated with hyperlipidemia and hypertension, respectively, were close to the null. Adjustments for age, sex, and other factors did not substantially change the risk ratio estimates.
Overweight, as compared to normal weight, was after multiple adjustments associated with approximately 30% decrease in risk of dying within 7 days after the MI. For obesity, as compared to normal weight, a similar association was observed: multiple adjusted RR 0.79 (95% CI 0.52-1.16) ( Table 2 ). Due to the known effects by cancer on BMI, we performed separate adjustment for previous hospitalizations with cancer as a primary or secondary diagnosis. The results did not substantially change the crude result: overweight RR 0.70 (95% CI 0.56-0.89) and obesity RR 0.85 (95% CI 0.62-1.10).
Analyses that included physical inactivity in multiple adjusted models generated results similar in magnitude as the ones presented in Table 2 : the respective RR of MI associated with diabetes, hypertension, hyperlipidemia, overweight and obesity were 1.51 (95% CI 1.08-2.06), 1.02 (95% CI 0.77-1.36), 0.96 (95% CI 0.72-1.26), 0.71 ( 95% CI 0.51-0.98) and 0.80 (95% CI 0.53-1.17) respectively.
Results from supplementary analyses, where adjustment for previous CVD was added to the main multiple adjusted models were similar to the results from the original final multiple adjusted models (data not shown).
Risk ratios of 28-day MI fatality associated with the metabolic risk factors under study were similar to the results obtained for 7-day MI fatality, as shown in Supplementary Table 1.
Discussion
In the current study based on the Stockholm general population aged 45 to 70 years, diabetes was associated with increased 7-dayfatality in patients with first time MI. This association was independent of age, sex, hypertension, hyperlipidemia, overweight, obesity, parental history of premature cardiac death, current smoking, low disposable income, educational level and general comorbidity. On the other hand, overweight was associated with a decreased 7-day MI fatality when compared to normal BMI. Hypertension and hyperlipidemia were not associated with MI fatality.
Our finding regarding diabetes is in agreement with two previous population-based studies (considering hospitalized MI cases as well as out-of-hospital CHD deaths), one based on middle-aged Finnish first time MI/CHD cases identified from 1988 to 1992 [10] and another based on middle-aged first time Australian MI/CHD cases identified from 1985 to 1994 [9] . The abovementioned Finnish [10] and Australian [9] population-based studies assessed diabetes near the MI event. In agreement with our findings on diabetes in relation to MI fatality, diabetes has been reported to increase fatality in cohorts of hospitalized MI patients [5, 6, 8, 20] .
One of several mechanisms proposed to explain why diabetes may increase MI fatality is related to damage in large size and small size arteries which in turn may reduce the blood supply in normal and infarcted myocardial tissue during the MI event [21] . A second mechanism, suggested from animal models, potentially explaining why diabetes might have a higher fatality is related to a decreased nitric oxide (NO) availability, which in turn may lead to vasoconstriction increasing the probability of the MI becoming fatal [22] . A third mechanism suggested relates to a reduction of the glucose usage by the heart cells among diabetes cases due to decreased translocation of the glucose transporter GLUT4 [21] . A fourth mechanism possibly explaining the connection between diabetes and MI fatality may relate to diabetes neuropathy that may lead to increased anginal perception threshold, which in turn may decrease the awareness of pain during myocardial ischemia. A lower level of pain may cause a delay in seeking care potentially leading to MI of large size and more prone to be fatal. The diabetes neuropathy may even render the MI silent. Silent MI is more common in individuals with diabetes than in those without [23] . Damaged cardiac tissue occurring after a silent MI may have adverse effect on survival of a newly recorded MI event. Thus, silent MI might be a potentially important mechanism of the effect of diabetes on MI fatality. Unfortunately, we had no information on silent MIs among non-fatal cases, thus we could not assess the importance of this mechanism. Due to limited data on diabetes treatment, the present study could not address whether MI fatality depends on the type of anti-diabetic treatment.
Our results regarding overweight and obesity, showing inverse relations to MI fatality, are in line with findings reported from several previous studies based on hospital admitted MI patients [24, 25] . Just as in our study, the precision of results on obesity was in most previous studies less than the precision of results on overweight. In a meta-analysis, robust results of an inverse association between obesity and MI fatality was shown [25] . In contrast, a previous population-based study (including hospitalized MI patients and out-of-hospital CHD deaths) reports no association between BMI and fatality of future CHD events [13] . One reason for the null result may be related to that BMI was modeled as a continuous variable which may conceal associations to MI fatality in BMI intervals. As there is no clear understanding of biological mechanisms that may explain why MI cases with overweight or obesity should have better short term survival than cases with normal BMI, our results must be interpreted with caution. In line with how Lavie et al. [26] discuss reasons for the "obesity paradox" which states that individuals with higher BMI have a lower cardiovascular risk [27, 28] and better prognosis after a CVD event [27] , from a biological perspective we speculate that our observed low 7-day MI fatality in overweight and obese individuals, as compared to normal BMI, may be due to an attenuated sympathetic activity of overweight individuals or to a greater metabolic reserve. Overweight and obese patients have larger fat storages which might serve as sources of energy that may be needed to survive a lifethreatening stressful event such as MI [29] . Another possibility is that a certain proportion of overweight individuals, classified according to their BMI have more muscle mass than individuals with normal BMI, which may protect from MI fatality [26] . Hence, an anthropometric measure that captures abdominal obesity better than BMI might have produced different results. Further, individuals with a low BMI may be more likely than overweight individuals to suffer from certain comorbidities that involve weight loss. These comorbidities may in turn decrease the chances of surviving an MI. Increased attention from medical staff and increased awareness of increased risk of health problems might also be important. Despite our adjustments for general comorbidity there may be residual confounding in our data. For instance, insulin resistance, usually undiagnosed, may involve weight loss and may be associated with MI fatality. Considering that self-reported BMI, which we have in our data, may be underestimated [30] , our results both on overweight and obesity may be diluted.
Our findings are in agreement with two population-based studies showing no association between hypertension and MI/CHD fatality [9, 14] . Other population-based studies, however, associated hypertension with increased MI/CHD fatality [13, 16] . Findings from a number of previous studies restricted to hospitalized MI cases agree with our findings of no association between hypertension and short-term prognosis after MI [6, 8, 11, 31, 32] . However, two large hospital-based American studies show inverse associations between hypertension and MI fatality [5, 33] . One possible reason for the discrepancy between our findings and findings from previous population-based studies that associated hypertension with increased MI/CHD fatality [13, 16] , may be related to differences in type and timing of assessments of hypertension between studies. In our study hypertension or treatment against hypertension was mainly self-reported or proxy-reported close in time to the MI event, whereas in the compared studies hypertension was determined from blood pressure measurements at baseline investigations taking place many years before the MI event [13, 16] . In our study hypertension may be underestimated due to failure of identifying hypertension in individuals with unknown hypertension. This underestimation should be equally frequent in non-fatal and fatal cases thus leading to a nondifferential misclassification moving results towards the null. The compared cohort studies, in turn, are also likely to have underestimated the prevalence of hypertension, both in fatal and non-fatal cases, because diagnoses of hypertension during follow-up were not considered. Thus, results would have moved towards the null. A limitation of the present study, as well as of any other epidemiological study investigating risk factors of MI fatality, is the lack of possibilities to distinguish between pre-event and post-event influences. If our finding of an association between diabetes and increased risk of MI fatality represents a causal relation, the effects exerted by diabetes may either act in the pre-event phase contributing to a severe MI more likely to be fatal, or act in the post-event phase by lowering the recovery capacity. A combination of pre-event and post-event influences is also possible. Overweight, on the other hand, may theoretically contribute to a mild form of MI [34] and/or positively influence the recovery capacity. In support of obesity being more likely to have a role in mild as opposed to severe MI are findings based on admitted MI patients showing less severe CHD in obese patients as compared to patients with normal weight [35] .
Our study has also other limitations. One of them is that the exposure assessments and MI events took place about 20 years ago which may compromise generalizability of findings to more recent settings. However, MI fatality and the proportion of out-of-hospital deaths among first ever fatal CHD events have remained similar [1] [2] 15] . The criteria to diagnose MI post-mortem have not changed over the years [36] . However, the criteria for pre-mortem diagnosis of MI have changed, mainly in that troponin is nowadays a preferred biomarker allowing detection of smaller size MI than did previous biomarkers [36] . Further, treatments of MI have improved leading to that severe cases reaching hospital now more often survive the acute phase [37] . Treatments of diabetes, hypertension and hyperlipidemia have improved and these risk factors are now detected earlier which may affect the generalizability of results. Another limitation of the present study is that the questionnaire data collected for fatal cases were provided by proxies who may under-or overestimate exposure in cases. However, according to results from a previous validation study performed based on SHEEP data, the proxy reports on variables used in the present study would in general agree with corresponding reports by the MI cases themselves [19] . Misclassification of our main exposures, if they occurred, are thus likely to be of similar magnitude in fatal and nonfatal cases, leading to a potential dilution of our results. An advantage with the case-control study design is however that it allows exposure assessments close in time to the index event.
An important strength of the SHEEP study is its well-functioning organization based on collaboration between all acute hospitals in Stockholm County to collect all incident hospitalized non-fatal and fatal cases. The organization also included a close collaboration with Statistics Sweden to simultaneously identify out-of-hospital fatal MI cases from the cause of death register. Additionally, the rate of participation was high. The possibility to consider several relevant potential confounding factors in this study is another advantage. Previous population-based studies of metabolic risk factor in relation to MI fatality had more limited possibilities to adjust for other covariates. An important strength is also the possibility we have to adjust for registerbased (and thus objective) data on disposable income and general comorbidity.
Another strength of this study is the high proportion of autopsies in fatal MI cases providing the opportunity to ascertain MI as a cause of death. Previous population-based studies of metabolic risk factors as determinants of CHD fatality did not distinguish sudden cardiac death from fatal MI [9, 10, 13, 14, 16] . Because causes of MI fatality may differ from causes of non-MI related sudden cardiac death, it is important for studies addressing etiological research questions to distinguish between those.
Our results emphasize the importance of close surveillance of individuals with a diagnosis of diabetes as they may be more prone to die would they suffer a first MI. Preventive work should perhaps also involve informing the public about the particular need for rapid hospital admission of individuals with diabetes if an MI is suspected -even if the pain is only moderate. Our observation of an inverse association between overweight and MI fatality may stimulate cardiovascular biology research on potential protective mechanisms in acute MI.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ijcme.2016.05.009. 
